![](/img/cover-not-exists.png)
3077 65 plus: A randomized phase III trial of Pemetrexed and Bevacizumab vs. Pemetrexed, Bevacizumab and Carboplatin as 1st line treatment for elderly patients with advanced non-squamous, non-small cell lung cancer (NSCLC) - a subgroup analysis of age and gender
Schuette, W., Nieman, B., Schneider, C.P., Engel-Riedel, W., Schumann, C., Kohlhaeufl, M., Serke, M., Hoeffken, G., Kortsik, C., Reck, M.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31718-x
Date:
September, 2015
File:
PDF, 60 KB
english, 2015